Ravi Shah Archive — Page 1 of 1

May 11, 2026

Multi-organ metabolite ‘signature’ signals increased heart failure risk

A multi-institutional group has identified a “signature” of metabolic molecules associated with exercise-induced physiologic deficits that, when released into the bloodstream, signal heightened heart failure risk.

By Bill Snyder
July 25, 2025

Ravi Shah named to co-direct Vanderbilt Diabetes Center

The Center oversees the NIH-funded Diabetes Research and Training Center, now in its 52nd year of continual operation, which advances innovative investigations related to the cause, prevention, treatment and complications of diabetes and obesity.

By Jill Clendening
July 15, 2025

Multidisciplinary study develops tools for new ‘genomics of interorgan communication’

The research characterizes the molecular “cargo” of circulating extracellular vesicles in obesity and links the findings to human genetic approaches to identify potential therapeutic targets for metabolic disease.

By Leigh MacMillan
This year’s awardees are, from left, Stokes Peebles, MD, Ravi Shah, MD, John Gore, PhD, and Jeffrey Davidson, PhD. (photo by Erin O. Smith)
February 14, 2025

VUMC honors four translational scientists

Translational research brings discoveries from the laboratory and preclinical studies to clinical trials and studies in humans.

By Bill Snyder
(iStock)
January 23, 2025

$20 million grant supports sweeping study of human viruses

Most of the more than 200 species of viruses known to reside in humans remain poorly understood, and new ones are being discovered every few months.

By Paul Govern
December 19, 2024

Proteomic signature a key to early detection of fatty liver disease: study

Currently, methods to detect early, obesity-related accumulation of fat in the liver other than a liver biopsy — the surgical removal of liver tissue for microscopic examination — are limited. But there is hope.

By Bill Snyder